Performance Comparison
Portfolio Performance Comparison
| Name | YTD Return | 1Yr AR | 3Yr AR | 5Yr AR | 10Yr AR | 15Yr AR | 20Yr AR | Common | Inception |
|---|---|---|---|---|---|---|---|---|---|
| MACK (Merrimack Pharmaceuticals Inc) | NA | 18.02% | 35.00% | 31.24% | -9.76% | NA | NA | … | … |
Data as of 05/17/2024, Common starting date is 03/29/2012
More Performance Analytics Comparison
| Name | Start Date | End Date |
|---|---|---|
| MACK (Merrimack Pharmaceuticals Inc) | 03/29/2012 | 05/17/2024 |
| Last 1 Week | 1 Yr | 3 Yr | 5 Yr | 10 Yr | 15 Yr | 20 Yr | Common | Inception | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annualized Return (%) | 0.07 | 18.02 | 35.00 | 31.24 | -9.76 | NA | NA | … | … | 12.83 | 17.02 | 193.09 | -43.25 | 118.73 | 3.72 | -62.34 | -74.88 | -48.35 | -30.09 | 112.01 | -12.48 | 0.83 |
| Sharpe Ratio | NA | 0.94 | 0.40 | 0.24 | -0.21 | NA | NA | … | … | 2.12 | 0.75 | 1.42 | -0.80 | 1.51 | -0.37 | -1.07 | -1.41 | -1.17 | -0.80 | 1.30 | -0.42 | -0.26 |
| Standard Deviation(%) | NA | 15.18 | 81.52 | 77.53 | 72.16 | NA | NA | … | … | 15.84 | 17.23 | 135.62 | 53.80 | 78.05 | 53.45 | 78.10 | 67.09 | 70.29 | 60.43 | 72.18 | 73.51 | 66.03 |
| Draw Down(%) | NA | 9.52 | 57.78 | 76.71 | 98.81 | NA | NA | … | … | 2.83 | 11.25 | 57.78 | 56.90 | 54.47 | 47.93 | 67.76 | 75.18 | 53.37 | 44.62 | 30.76 | 70.57 | 45.61 |
| Yield(%) | 0.00 | 0.00 | 0.00 | 8.46 | 0.57 | 0.43 | 0.32 | … | … | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 62.53 | 0.00 | 3.35 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Data as of 05/17/2024, Common starting date is 03/29/2012
Performance Comparison Chart
Annualized Rolling Returns Comparison (Minimum)
| Ticker/Portfolio Name | 3 Year | 5 Year | 10 Year | 15 Year |
|---|---|---|---|---|
| MACK (Merrimack Pharmaceuticals Inc) |
-65.41%
Jun 2015 – Jun 2018 |
-50.70%
Mar 2015 – Mar 2020 |
-23.99%
Sep 2012 – Sep 2022 |
0.00%
NA |
Annualized Rolling Returns Comparison (Maximum)
| Ticker/Portfolio Name | 3 Year | 5 Year | 10 Year | 15 Year |
|---|---|---|---|---|
| MACK (Merrimack Pharmaceuticals Inc) |
78.80%
Mar 2020 – Mar 2023 |
39.93%
Dec 2018 – Dec 2023 |
-3.04%
Oct 2013 – Oct 2023 |
0.00%
NA |
Annualized Rolling Returns Comparison Chart